Skip to content
Screener

Baxter International BAX Q2 2026 earnings

Reported July 30, 2026 · Before market open

Revenue$3.0BBeat by $164.5M
EPS$0.56Beat by $0.19
Revenue estimate$2.8B
EPS estimate$0.37
“While we're encouraged by this steady progress and core operating momentum, we remain focused on the work ahead. Guided by the Baxter Growth and Performance System (GPS), we're focused on further stabilizing the business, strengthening the balance sheet and driving a culture of continuous improvement as we build a stronger, more resilient company.”
Andrew Hider

Next report

Date not yet announced

Financials

Q2 2026

Income statement

See full
Revenue$3.0B+5.3%
Gross profit$1.0B+4.1%
Operating income$217.0M+13.6%
Net income$126.0M+38.5%
EPS (diluted)$0.24+33.3%

Balance sheet

See full
Cash & equivalents$2.2B+27.4%
Total debt$208.0M-10.0%
Total equity$6.2B-15.2%
Total assets$19.8B-6.0%

Cash flow

See full
Operating cash flow$285.0M+31.3%

Valuation & ratios

Valuation

as of 06/30/26
See full
Market cap$11.01B-29.9%
Enterprise value$9.07B-36.3%
P/S1×-0.5×

Profitability

See full
Gross margin30.1%-5.2pp
Operating margin-2.4%—
Net margin-9.3%-11.3pp

Returns & leverage

See full
Return on equity-15.7%-18.5pp
Debt / equity0×0.0×
Current ratio1.9×-0.4×

Segments

By product

See full
Infusion Therapies & Platforms$1.7B—
Care & Connectivity Solutions$502.0M+5.9%
Advanced Surgery$331.0M+11.8%
Front Line Care$299.0M+2.0%

By segment

See full
Medical Products & Therapies$2.1B+57.3%
Healthcare Systems & Technologies$801.0M+4.4%

By geography

See full
International$1.4B—

FAQ

When did Baxter International report Q2 2026 earnings?
Baxter International (BAX) reported Q2 2026 earnings on July 30, 2026 before market open.
What were Baxter International's Q2 2026 revenue and EPS?
Baxter International reported revenue of $3.0B and eps of $0.56 for Q2 2026.
Did Baxter International beat estimates in Q2 2026?
Revenue beat the consensus estimate of $2.8B by $164.5M. EPS beat the consensus estimate of $0.37 by $0.19.
How did Baxter International's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.3% from $2.8B a year earlier and eps declined 5.1% from $0.59.
Where can I find Baxter International's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-050795) and the 10-Q periodic report (0001628280-26-051118) directly on SEC EDGAR. The filing index links above go to sec.gov.